Dyadic International Inc., DE (DYAI) Company Profile & Statistics

Dyadic International Inc., DE
DYAI
(Nasdaq - US)
Closed
1.05
+0.00 (0.00%)
in:usd•As of: Nov 05, 2024 14:26 UTC -5
Open
1.03
High
1.07
Low
1.03

About Dyadic International Inc., DE

CEO

Mark A. Emalfarb

Headquarters

1044 north u.s. highway one, suite 201

jupiter, fl 33477, united states

Auditor

Crowe LLP

Employees

Share Holders

Website

www.dyadic.com

Industry

medical or nursing services

Sector

health services

Company Overview

Dyadic International, Inc. is a leading genomics company with the groundbreaking technology that brings nature to the marketplace. Dyadic is poised to become a global leader in proteomics through the discovery, development, and manufacturing of novel products derived from the DNA of complex living organisms including humans found in the earth's biodiversity. Using its integrated technology platform, Dyadic develops biological products such as proteins, enzymes, polypeptides and small molecules for applications in large segments of the agricultural, industrial, chemical and biopharmaceutical industries. By utilizing a proprietary host organism, Dyadic's `one-stop shop` technology rapidly discovers and expresses eukaryotic genes the genes of complex living organisms and then manufactures those unique biological products for commercial application. Dyadic's systems overcome the inadequacy of existing gene discovery and product development techniques.

Dyadic International Inc., DE Statistics

Valuation Measures

Market Capitalization ²	30.95M
Enterprise Value	30.27M
Enterprise Value/EBITDA (ttm)	-3.74
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	9.78
Price to Sales (ttm)	17.31
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	50.27%
Operating Margin (ttm)	-428.86%
Profit Margin (ttm)	-459.72%
Return on Equity (ttm)	-145.95%
Return on Invested Capital (ttm)	-99.50%
Return on Assets (ttm)	-75.92%

Income Statement

Revenue (ttm)	1.80M
Revenue Per Share (ttm)	0.06
Gross Profit (ttm)	902.20K
EBITDA (ttm)³	-8.09M
Net Income Avi to Common (ttm)	-7.74M
Diluted EPS (ttm)	-0.28

Share Statistics

Beta (5Y Monthly)	0.72
52-Week Change	-37.13%
S&P500 52-Week Change	32.45%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	29.48M
Dividend Yield	0.00%
Float ⁴	20.99M
% Held by Insiders	28.80%
% Held by Institutions	27.95%

Balance Sheet

Total Cash (mrq)	10.10M
Total Cash Per Share (mrq)	0.34
Total Debt (mrq)	5.45M
Total Debt/Equity (mrq)	172.06%
Current Ratio (mrq)	5.39%
Quick Ratio (mrq)	5.39%
Book Value Per Share (mrq)	0.11

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.11
Free Cash Flow (ytd)	-3.08M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Dyadic International Inc., DE

Trade With A Regulated Broker